DaVita Clinical Research

Houston, Texas 77054

2 studies enrolling now · 7 studies all time

What they study most

Calcific Uremic Arteriolopathy, Calciphylaxis, Chronic Kidney Disease, Chronic Kidney Disease Requiring Chronic Dialysis, Chronic Kidney Diseases, Diabetic Kidney Disease, Diabetic Nephropathies, End Stage Kidney Disease, End Stage Renal Disease on Dialysis, Hyperphosphatemia

Studies at this site

• A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN) — Completed
• A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease — Completed
• Phase 3 Study of SNF472 for Calciphylaxis — Completed
• A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease — Stopped early
• Study to Evaluate the Efficacy and Safety of Selonsertib in Participants With Moderate to Advanced Diabetic Kidney Disease — Completed